The increasing demand for affordable healthcare and the expiration of patents for branded medicines are driving the growth of generic pharmaceuticals worldwide. However, the market also faces several challenges. Intense price competition, strict regulatory approval processes, supply chain disruptions, and quality compliance requirements can impact profitability for manufacturers. In addition,...

According to a new report from Intel Market Research, the global Antihypertensive Drugs market was valued at USD 31.96 billion in 2024 and is projected to grow from USD 33.12 billion in 2025 to reach USD 40.62 billion by 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034). This steady growth trajectory is underpinned by the escalating global burden of hypertension,...

According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...